​

Funding Round

Post-IPO Equity - New Amsterdam Pharma

Post-IPO Equity - New Amsterdam Pharma

Investment Firm

Overview

New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.

Announced Date

Nov 23, 2022

Funding Type

Post Ipo Equity

Highlights

Location

Europe

Social

Investor Lead

N/A

Participant Investors

7

Investor Name
Participant InvestorBain Capital Life Sciences
Participant InvestorRA Capital Management
Participant InvestorForbion Capital Partners
Participant InvestorMedicxi
Participant InvestorFrazier Healthcare Partners

Round Details and Background

New Amsterdam Pharma raised $235000000 on 2022-11-23 in Post-IPO Equity

New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 01, 2019
Venture Round - New Amsterdam Pharma
1-undefined
Nov 23, 2022
Post-IPO Equity - New Amsterdam Pharma
9-235.0M
Jun 06, 2023
Post-IPO Secondary - New Amsterdam Pharma
-181.6M
Feb 13, 2024
Post-IPO Equity - New Amsterdam Pharma
-175.3M

Recent Activity

There is no recent news or activity for this profile.